BioSpace News Archive

Checkmate Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused upon activation of innate immunity to treat cancer, today announced two oral presentations at The 34th Annual Meeting of The Society for Immunotherapy of Cancer (SITC).

Validant, a leading transatlantic quality, compliance and regulatory consulting group, has acquired DataRevive, a regulatory strategy and consultancy firm that focuses on supporting pharma and biotech to navigate the regulatory approval pathway for global clients in the US market.

Top industry leaders in drug development, digital health and technology are meeting at CNS Summit 2019 to collaborate on initiatives and programs that will reshape the future of the life science sector.

HealthTrust has awarded a 36-month group purchasing agreement effective November 1, 2019 for EcoVue ultrasound gel to York, Pennsylvania based HR Pharmaceuticals, Inc.

Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), is pleased to announce that it has entered into an asset purchase agreement with Neuro-Pro Monitoring (Neuro-Pro) and its affiliated entities (each, an “Affiliate”, collectively, the “Affiliates” and together with Neuro-Pro, the “Vendors”), one of the largest IONM service providers in Texas, pursuant to which the Company has conditionally acquired (the “Acquisition”) all of the assets of Neuro-Pro

Connexient, the healthcare leader in digital wayfinding and indoor navigation, just completed its strongest quarter ever with impressive wins at some of the leading health systems in the country.

Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVA™ (eravacycline for injection) to treat serious and life-threatening infections, today announced the completion of its previously announced registered direct offering to a healthcare-focused institutional investor priced at-the-market,

MYR Pharmaceuticals announced the presentation of a number of results on bulevirtide at the upcoming meeting of American Association for the Study of Liver Diseases, in Boston, US.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, is supporting the efforts of Beyond Type 1, a global diabetes advocacy organization, in fielding its largest marathon team in history, made up of 30 runners with a combined 385 years of experience living with type 1 diabetes.

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN, the “Company”), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today reported financial results for the quarter ended September 30, 2019, and provided a review of recent accomplishments and anticipated milestones.